Gender differences in psychiatric comorbidity among cocaine-using opiate addicts

Area of Science:

• Psychiatry
• Addiction Medicine
• Clinical Psychology

Background:

• Dual addiction to opiates and cocaine presents complex treatment challenges.
• Understanding psychiatric comorbidity in this population is crucial for effective care.
• Gender differences in psychiatric disorders may influence treatment outcomes.

Purpose of the Study:

• To examine psychiatric comorbidity in methadone patients dually addicted to opiates and cocaine.
• To investigate gender differences in the prevalence and patterns of psychiatric disorders.
• To identify specific comorbidity profiles associated with gender.

Main Methods:

• A sample of 212 methadone patients were assessed for psychiatric comorbidity.
• Diagnoses were determined using the Structured Clinical Interview for DSM-III-R (SCID).
• Data were analyzed to identify gender-specific patterns of substance use and non-substance use disorders.

Main Results:

• Men had more lifetime substance use disorders, while women had more lifetime and current non-substance use disorders.
• Women were more likely to have concurrent mood and anxiety disorders.
• Specific comorbidity patterns emerged: women with Antisocial Personality Disorder (ASPD) were less likely to have alcohol use disorder but more likely to have opioid use disorder; men with anxiety were often diagnosed with ASPD.

Conclusions:

• Gender significantly influences psychiatric comorbidity profiles in dually addicted methadone patients.
• Tailoring treatment strategies based on gender-specific comorbidities is recommended.
• Further research is needed to explore the clinical implications of these findings for addiction treatment.